Access cutting-edge breast cancer treatment through this clinical trial at a research site in San Francisco. Study-provided care at no cost to qualified participants.
Access breast cancer specialists in San Francisco at no cost
This study follows strict safety protocols and ethical guidelines
All study-related breast cancer treatment provided free
This research study is studying how well newly diagnosed breast cancer that has tested positive for a protein called HER2 responds using one of two different combination of HER2-directed therapies as a treatment after surgery. The name of the study drugs involved are: * Trastuzumab-emtansine (T-DM1, Kadcyla) * Trastuzumab SC (Herceptin Hylecta) * Paclitaxel
Sponsor: Dana-Farber Cancer Institute
Check if you qualify for this breast cancer clinical trial in San Francisco, CA
If you're searching for breast cancer treatment options in San Francisco, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our San Francisco research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.